Quiroga Vanesa - Badalona Applied Research Group in Oncology (B-ARGO Group), Catalan Institute of Oncology

基本信息

浏览量：12

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 105 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Molecular Characterization of the Residual Disease after Neoadjuvant Endocrine Therapy in ER+/HER2- Breast Cancer Uncovers Biomarkers of Tumour Response

Joanna I. López-Velazco,Sara Manzano,Kepa Elorriaga,Maria Otaño,Ainhara Lahuerta, Luis Álvarez, Inge Etxabe, Miren Huarte,Elvira Buch, Julia Gimenez,Vanesa Quiroga, Marta Fernandez, Sofía Aragón,Laia Paré,Aleix Prat,Isabel Álvarez-López,MARIA CAFFAREL,Ander Urruticoechea

crossref（2024）

引用0浏览0引用

Deciphering HER2-low Breast Cancer (BC): Insights from Real-World Data in Early Stage Breast Cancer

Anna Pous,Adria Bernat-Peguera,Assumpcio Lopez-Paradis,Beatriz Cirauqui,Vanesa Quiroga,Iris Teruel,Eudald Felip,Angelica Ferrando-Diez,Milana Bergamino, Laia Boronat,Margarita Romeo,Gemma Soler, Christian Marino, Paula Rodriguez-Martinez,Laura Pons,Ester Ballana,Anna Martinez-Cardus, Mireia Margeli

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2024)

引用0浏览0WOS引用

Genomic Variability Within Intrinsic Subtypes of Advanced Breast Cancer

Cecilia Perello-Fabregat,Aintzane Urbizu,Laura Arnaldo,Carolina Sanz, Ana M. Munoz-Marmol,Laura Pons, Paula Rodriguez-Martinez,Eva Castella, Laura Hernandez Leon,Ana Castillo Gandia, Micaella Aquino, Paula Osorio, Hector Moreno Garrido, Eva Fernandez Lopez,Beatriz Cirauqui,Iris Teruel,Vanesa Quiroga,Eudald Felip, Institut Catala Badalona,Mireia Margeli,Pedro Fernandez

LABORATORY INVESTIGATIONno. 3 (2024): S236-S237

引用0浏览0引用

Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy

Iris Teruel,Eva Castellà,Sabela Recalde,Gemma Viñas,Anna Petit,Macedonia Trigueros, Eva Martínez-Balibrea,Eudald Felip,Milana Bergamino,Adrià Bernat-Peguera,Beatriz Cirauqui,Vanesa Quiroga,Angelica Ferrando-Díez,Anna Pous, Assumpció López, Laia Boronat,Gemma Soler, Jordi Recuero,Margarita Romeo, Pau Guillén, Ricard Mesía, Ester Ballana,Anna Martínez-Cardús, Mireia Margelí

International journal of molecular sciencesno. 22 (2024)

引用0浏览0WOS引用

Elderly Patients with Hormone Receptor-Positive HER2-negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors in a Multicentre Cohort

Helena Pla,Eudald Felip,Verónica Obadia,Sonia Pernas,Gemma Viñas,Mireia Margelí, Roser Fort-Culillas,Sonia Del Barco, Nuria Sabaté,Eduard Fort,Clara Lezcano,Beatriz Cirauqui,Vanesa Quiroga,Agostina Stradella, Gil,Anna Esteve,Sabela Recalde

CLINICAL & TRANSLATIONAL ONCOLOGYno. 7 (2024): 1748-1758

引用0浏览0WOS引用

Neoadjuvant Letrozole and Palbociclib in Patients with HR-positive/HER2-negative Early Breast Cancer and Oncotype DX Recurrence Score ≥18: DxCARTES Study

Á Guerrero-Zotano,J M Pérez-García,M Ruiz-Borrego,B Bermejo,M Gil-Gil,J de la Haba,E Alba Conejo,V Quiroga,V Carañana,A Urruticoechea,S Morales, M Bellet,A Antón,M Fernández-Abad,P Sánchez-Rovira, L Calabuig, J Pérez-Escuredo,M Sampayo-Cordero, J Cortés,A Llombart-Cussac

ESMO openno. 10 (2024): 103733-103733

引用0浏览0WOS引用

Exploring HER2-low Disease: Does It Impact Breast Cancer Survival

Assumpcio Lopez-Paradis,Anna Pous,Adria Bernat-Peguera,Vanesa Quiroga,Beatriz Cirauqui,Eudald Felip,Milana Bergamino,Angelica Ferrando-Diez,Marga Romeo,Iris Teruel,Anna Martinez-Cardus,Mireia Margeli

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Exploratory gene expression analysis of coopERA Breast Cancer (BC): a study evaluating neoadjuvant giredestrant versus anastrozole alone and in combination with palbociclib in ER-positive, HER2-negative untreated early BC

Alejandro M. Chibly,Tharu M. Fernando,Ciara Metcalfe,Marc Hafner,Gilbert Owusu-Manu,Sara Hurvitz,Aditya Bardia, Peter A. Fasching,Yeon H. Park,Vanesa Quiroga,Jutta Steinseifer,Pablo Perez-Moreno,Heather M. Moore

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn